Your browser doesn't support javascript.
loading
Corrigendum: Nitazoxanide, an antiprotozoal drug, reduces bone loss in ovariectomized mice by inhibition of RANKL-induced osteoclastogenesis.
Li, Chang-Hong; Lü, Zi-Rui; Zhao, Zhen-da; Wang, Xin-Yu; Leng, Hui-Jie; Niu, Yan; Wang, Mo-Pei.
Afiliação
  • Li CH; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, China.
  • Lü ZR; Osteoporosis and Bone Metabolic Diseases Center, Peking University Third Hospital, Beijing, China.
  • Zhao ZD; Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.
  • Wang XY; Osteoporosis and Bone Metabolic Diseases Center, Peking University Third Hospital, Beijing, China.
  • Leng HJ; Department of Orthopaedics, Peking University Third Hospital, Beijing, China.
  • Niu Y; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, China.
  • Wang MP; Osteoporosis and Bone Metabolic Diseases Center, Peking University Third Hospital, Beijing, China.
Front Pharmacol ; 14: 1247393, 2023.
Article em En | MEDLINE | ID: mdl-37564185
ABSTRACT
[This corrects the article DOI 10.3389/fphar.2021.781640.].
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China